The pharmaceutical sector in Europe displays varying dynamics in the number of high-growth enterprises across countries. Italy leads with 51 enterprises. Czech Republic and Portugal follow with noticeable growth rates of 28.99% and 18.29% respectively in 2023, indicating strong expansion. Latvia’s rapid growth of 51.57% marks it as a significant emerging market, though from a smaller base. In contrast, Hungary and Slovakia experience slight declines at -2.64% and -4.36% respectively, while Romania, Norway, and Iceland remain stagnant. The long-term outlook reveals robust activity with varied impacts driven by regulatory environments and market opportunities.
Future trends to watch include:
- Continued growth in Eastern Europe as markets mature.
- Regulatory impacts such as pricing reforms potentially affecting growth rates.
- Innovation and technological advancements driving enterprise expansion.
- Strategic mergers and partnerships influencing market dynamics.
Top countries in Number of High Growth Enterprises in Pharmaceutical Preparations by Country
| # | 10 Countries | Units (Enterprises) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 51 | 2023 | -1.92% | +3.96% | View data |
| 2 | 2 Czech Republic | 25 | 2023 | +8.7% | +28.99% | View data |
| 3 | 3 Portugal | 22 | 2023 | +10% | +18.29% | View data |
| 4 | 4 Latvia | 8 | 2023 | +14.29% | +51.57% | View data |
| 5 | 5 Hungary | 7 | 2023 | 0% | -2.64% | View data |
| 6 | 6 Lithuania | 5 | 2023 | +25% | +25.74% | View data |
| 7 | 7 Slovakia | 4 | 2023 | 0% | -4.36% | View data |
| 8 | 8 Romania | 3 | 2023 | 0% | 0% | View data |
| 9 | 9 Norway | 2 | 2023 | 0% | 0% | View data |
| 10 | 10 Iceland | 2 | 2023 | 0% | 0% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
